Record levels of US adults report using marijuana in the last year, while hallucinogen use also rises significantly, NIH survey shows; meanwhile, use of cigarettes, sedatives and non-medical opioids declined over past 10 years

Sample article from our Consumer Wellness

August 17, 2023 (press release) –


A record 44% of adults aged 19-30 and 28% of adults aged 35-50 reported using marijuana last year, the National Institutes of Health reported today.

An estimated 8% of adults aged 19-30 and 4% of adults aged 35-50 reported using hallucinogens, up from 3% and 1%, respectively, a decade ago.

Among other findings from the annual Monitoring the Future survey, alcohol use increased 2% over the past five years in adults aged 19-30 and 2% over 10 years in adults aged 35-50.

Use of cigarettes, sedatives and non-medical opioids declined for both age groups over the past 10 years, while amphetamine use declined for 19-30 year olds but increased for 35-50 year olds.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order consumer wellness coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.